Cargando…
Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center
Tremendous progress has been made in the recognition of primary immune deficiencies (PIDs) in Bulgaria since in 2005 we have joined the J Project Central-Eastern European collaborative program. Ten years later an Expert Centre (ExpC) for Rare Diseases - Primary Immune Deficiencies at the University...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535737/ https://www.ncbi.nlm.nih.gov/pubmed/36211402 http://dx.doi.org/10.3389/fimmu.2022.922752 |
_version_ | 1784802839377215488 |
---|---|
author | Naumova, Elissaveta Lesichkova, Spaska Milenova, Veneta Yankova, Petya Murdjeva, Marianna Mihailova, Snezhina |
author_facet | Naumova, Elissaveta Lesichkova, Spaska Milenova, Veneta Yankova, Petya Murdjeva, Marianna Mihailova, Snezhina |
author_sort | Naumova, Elissaveta |
collection | PubMed |
description | Tremendous progress has been made in the recognition of primary immune deficiencies (PIDs) in Bulgaria since in 2005 we have joined the J Project Central-Eastern European collaborative program. Ten years later an Expert Centre (ExpC) for Rare Diseases - Primary Immune Deficiencies at the University Hospital “Alexandrovska”- Sofia was established. In May 2017 The National Register of Patients with Rare Diseases also became operational as a database containing clinical and genetic information for Bulgarian patients with PID. The transfer of data and information on Bulgarian PID patients to the European Primary Immunodeficiency Database, managed by the European Society for Primary Immunodeficiency (ESID) has started in 2020. The total number of registered patients now is 191 (100 men and 91 women), with more than half of them being children (106; 55.5%). Regular updating of the information in the register showed that 5.2% of patients are deceased and the majority (94.8%) is a subject to continuous monitoring as it has been reported for other European countries as well. With the establishment of the ExpC, the dynamics in the diagnosis and registration of patients with PID significantly intensified. For a period of 5 years (2016-2021) 101 patients were evaluated and registered in comparison with previous period - before ExpC establishment when only 89 patients were diagnosed. The most common pathology was humoral immune deficiency (85 patients; 44.5%). Ninety-six (50.3%) of the patients underwent genetic testing, and 66. 7% had genetically confirmed diagnosis. Three of the variants have not been reported in population databases. Following genetic investigation confirmation of the initial phenotypic diagnosis was achieved in 82.8% of cases and change in the diagnosis - in 17%. Sixty-two patients were on regular replacement or specific therapy, and the rest received symptomatic and supportive treatment. In summary, we present the first epidemiological report of PIDs in Bulgaria, based on the National PID register. Data on the clinical, phenotypic and genetic characteristics of PID patients provided important information about the nature of primary immunodeficiency diseases in our country. |
format | Online Article Text |
id | pubmed-9535737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-95357372022-10-07 Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center Naumova, Elissaveta Lesichkova, Spaska Milenova, Veneta Yankova, Petya Murdjeva, Marianna Mihailova, Snezhina Front Immunol Immunology Tremendous progress has been made in the recognition of primary immune deficiencies (PIDs) in Bulgaria since in 2005 we have joined the J Project Central-Eastern European collaborative program. Ten years later an Expert Centre (ExpC) for Rare Diseases - Primary Immune Deficiencies at the University Hospital “Alexandrovska”- Sofia was established. In May 2017 The National Register of Patients with Rare Diseases also became operational as a database containing clinical and genetic information for Bulgarian patients with PID. The transfer of data and information on Bulgarian PID patients to the European Primary Immunodeficiency Database, managed by the European Society for Primary Immunodeficiency (ESID) has started in 2020. The total number of registered patients now is 191 (100 men and 91 women), with more than half of them being children (106; 55.5%). Regular updating of the information in the register showed that 5.2% of patients are deceased and the majority (94.8%) is a subject to continuous monitoring as it has been reported for other European countries as well. With the establishment of the ExpC, the dynamics in the diagnosis and registration of patients with PID significantly intensified. For a period of 5 years (2016-2021) 101 patients were evaluated and registered in comparison with previous period - before ExpC establishment when only 89 patients were diagnosed. The most common pathology was humoral immune deficiency (85 patients; 44.5%). Ninety-six (50.3%) of the patients underwent genetic testing, and 66. 7% had genetically confirmed diagnosis. Three of the variants have not been reported in population databases. Following genetic investigation confirmation of the initial phenotypic diagnosis was achieved in 82.8% of cases and change in the diagnosis - in 17%. Sixty-two patients were on regular replacement or specific therapy, and the rest received symptomatic and supportive treatment. In summary, we present the first epidemiological report of PIDs in Bulgaria, based on the National PID register. Data on the clinical, phenotypic and genetic characteristics of PID patients provided important information about the nature of primary immunodeficiency diseases in our country. Frontiers Media S.A. 2022-09-22 /pmc/articles/PMC9535737/ /pubmed/36211402 http://dx.doi.org/10.3389/fimmu.2022.922752 Text en Copyright © 2022 Naumova, Lesichkova, Milenova, Yankova, Murdjeva and Mihailova https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Naumova, Elissaveta Lesichkova, Spaska Milenova, Veneta Yankova, Petya Murdjeva, Marianna Mihailova, Snezhina Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center |
title | Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center |
title_full | Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center |
title_fullStr | Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center |
title_full_unstemmed | Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center |
title_short | Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center |
title_sort | primary immunodeficiencies in bulgaria - achievements and challenges of the pid national expert center |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535737/ https://www.ncbi.nlm.nih.gov/pubmed/36211402 http://dx.doi.org/10.3389/fimmu.2022.922752 |
work_keys_str_mv | AT naumovaelissaveta primaryimmunodeficienciesinbulgariaachievementsandchallengesofthepidnationalexpertcenter AT lesichkovaspaska primaryimmunodeficienciesinbulgariaachievementsandchallengesofthepidnationalexpertcenter AT milenovaveneta primaryimmunodeficienciesinbulgariaachievementsandchallengesofthepidnationalexpertcenter AT yankovapetya primaryimmunodeficienciesinbulgariaachievementsandchallengesofthepidnationalexpertcenter AT murdjevamarianna primaryimmunodeficienciesinbulgariaachievementsandchallengesofthepidnationalexpertcenter AT mihailovasnezhina primaryimmunodeficienciesinbulgariaachievementsandchallengesofthepidnationalexpertcenter |